TransCode Therapeutics, Inc. Announces $8 Million Private Placement
27 nov. 2024 07h00 HE
|
TransCode Therapeutics, Inc.
TransCode Therapeutics, Inc. Announces $8 Million Private Placement
Baylor Genetics Wins BioTech Breakthrough Award
19 nov. 2024 10h00 HE
|
Baylor Genetics
Baylor Genetics announced its selection as the 2024 winner of the “Overall Genomics Solution of the Year" from BioTech Breakthrough.
North America RNA Therapeutics Market Research 2024-2029: Revolutionary Advancements in RNA Technology and Personalized Medicine Propel Growth
14 nov. 2024 05h21 HE
|
Research and Markets
Dublin, Nov. 14, 2024 (GLOBE NEWSWIRE) -- The "North America RNA Therapeutics Market, By Country, Competition, Forecast & Opportunities, 2019-2029F" report has been added to ...
Cell And Gene Therapy Market Size to Worth USD 190.82 Billion by 2033 | Straits Research
07 nov. 2024 09h30 HE
|
Straits Research Private Limited - Garner Insights
New York, United States , Nov. 07, 2024 (GLOBE NEWSWIRE) -- “Cell therapy” refers to the process of administering live cells to patients with the purpose of treating various diseases. Both...
TransCode Therapeutics Announces Safety Review Committee Approval of Second Cohort Opening in Phase 1 TTX-MC138 Clinical Trial Following Favorable Review of Cohort 1 Safety Data
23 oct. 2024 07h00 HE
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Announces Safety Review Committee Approval of Second Cohort Opening in Phase 1 TTX-MC138 Clinical Trial Following Favorable Review o
Cytosurge and Lexogen Partner to Advance Live-Cell Sequencing
15 oct. 2024 09h00 HE
|
Cytosurge AG; Lexogen GmbH
Cytosurge and Lexogen partner to advance Live-seq, integrating FluidFM® and LUTHOR HD to enable scalable, live-cell transcriptomics with high sensitivity.
Nucleic Acid Therapeutics CDMO Industry Outlook, 2024-2030 - Increasing Demand for One-Stop-Shop CDMOs and Growing FDIs in Nucleic Acid Therapeutics
10 oct. 2024 12h30 HE
|
Research and Markets
Dublin, Oct. 10, 2024 (GLOBE NEWSWIRE) -- The "Nucleic Acid Therapeutics CDMO Market Size, Share & Trends Analysis, 2024-2030" report has been added to ResearchAndMarkets.com's offering.The...
RNA Sequencing Market Opportunities - Harnessing Blockchain and Cloud Computing Technologies and Technological Advances in RNA Isolation and Extraction Processes
07 oct. 2024 05h08 HE
|
Research and Markets
Dublin, Oct. 07, 2024 (GLOBE NEWSWIRE) -- The "RNA Sequencing: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. This research report covers the global...
TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate
17 sept. 2024 07h00 HE
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate
TransCode Therapeutics Awarded $2 Million NIH Grant to Support Clinical Evaluation of Lead Candidate
05 sept. 2024 07h00 HE
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Awarded $2 Million NIH Grant to Support Clinical Evaluation of Lead Candidate